Findings of a trial with pemafibrate in a contemporary patient population5' education - Dec. 7, 2022 - Prof. Paul Ridker, MD - Boston, MA, USA
This video was recorded at AHA Scientific Sessions 2022 in Chicago, IL, USA.
Paul M Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, USA.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.